Table 2.

Baseine characteristics (age, sex, percentage predicted Forced expiratory rate in the first second (FEV1), Inhaled Cosirosteroid (ICS) dose in mcg/dat beclomethasone equivalent, ciuurent smoking status in groups randomsied to AKL followed by placebo or to placebo followed by AKL, with p values for differences between groups.

	age (median, IQR)	Female sex (n)	FEV1 % predicted (median, IQR)	ICS dose, mcg/day (median, IQR)	Current smoker (n)
AKL1 – Placebo (n = 16)	41.00, 33.50 – 55.75	13	90.00, 79.75 – 115.50	1000, 400 – 2000	1
Placebo – AKL1 (n = 16)	35.50, 29.50 – 55.50	12	85.50, 56.50 – 110.00	800, 400 – 1150	1
P value	0.67	0.67	0.25	0.51	1.00